This approval augments Biocon Pharma's complex injectables portfolio and reinforces its footprint in the US pharma market.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback